Development and Validation of the Multidimensional COVID-19 Vaccine Hesitancy Scale
The aim of the study was to develop and validate the Multidimensional Covid-19 Vaccine Hesitancy Scale (CoVaH), a self-report measure to assess the beliefs and attitudes beneath vaccination hesitancy and reasons for vaccine refusal in the context of Covid-19. A sample of 1503 Hungarian respondents f...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2022-01-01
|
| Series: | Human Vaccines & Immunotherapeutics |
| Subjects: | |
| Online Access: | http://dx.doi.org/10.1080/21645515.2021.2007708 |
| _version_ | 1797673225264562176 |
|---|---|
| author | Ibolya Kotta Kinga Kalcza-Janosi Kinga Szabo Eszter Eniko Marschalko |
| author_facet | Ibolya Kotta Kinga Kalcza-Janosi Kinga Szabo Eszter Eniko Marschalko |
| author_sort | Ibolya Kotta |
| collection | DOAJ |
| description | The aim of the study was to develop and validate the Multidimensional Covid-19 Vaccine Hesitancy Scale (CoVaH), a self-report measure to assess the beliefs and attitudes beneath vaccination hesitancy and reasons for vaccine refusal in the context of Covid-19. A sample of 1503 Hungarian respondents filled out the scale. Exploratory and confirmatory factor analysis was conducted to identify latent constructs underlying participants′ responses. Findings show a robust three-factor solution for the 15-item CoVaH with high factor loadings on each factor: skepticism, risk perception and fear of Covid-19 vaccine. The CoVaH displayed very good fit indices (KMO = .94, RMSEA = 0.049, CFI = .983) and internal consistencies (α values > .89) and was found to have proper convergent, concurrent and discriminant validity in identifying Covid-19 vaccine hesitancy in the general population. The new scale adds to the literature through the identification of the fear of COVID-19 vaccines, as a newly highlighted explanatory variable of COVID-19 vaccine hesitancy, besides the other formerly identified components. The scale, available in English and Hungarian, allows the assessment of vaccine uptake hesitancy and has the potential to help targeted interventions, considering individual factors that interfere with vaccination acceptance. |
| first_indexed | 2024-03-11T21:42:25Z |
| format | Article |
| id | doaj.art-28d3d9db171e4a14aaf5c10f64b95391 |
| institution | Directory Open Access Journal |
| issn | 2164-5515 2164-554X |
| language | English |
| last_indexed | 2024-03-11T21:42:25Z |
| publishDate | 2022-01-01 |
| publisher | Taylor & Francis Group |
| record_format | Article |
| series | Human Vaccines & Immunotherapeutics |
| spelling | doaj.art-28d3d9db171e4a14aaf5c10f64b953912023-09-26T12:53:16ZengTaylor & Francis GroupHuman Vaccines & Immunotherapeutics2164-55152164-554X2022-01-0118111010.1080/21645515.2021.20077082007708Development and Validation of the Multidimensional COVID-19 Vaccine Hesitancy ScaleIbolya Kotta0Kinga Kalcza-Janosi1Kinga Szabo2Eszter Eniko Marschalko3Babes-Bolyai UniversityBabes-Bolyai UniversityBabes-Bolyai UniversityBabes-Bolyai UniversityThe aim of the study was to develop and validate the Multidimensional Covid-19 Vaccine Hesitancy Scale (CoVaH), a self-report measure to assess the beliefs and attitudes beneath vaccination hesitancy and reasons for vaccine refusal in the context of Covid-19. A sample of 1503 Hungarian respondents filled out the scale. Exploratory and confirmatory factor analysis was conducted to identify latent constructs underlying participants′ responses. Findings show a robust three-factor solution for the 15-item CoVaH with high factor loadings on each factor: skepticism, risk perception and fear of Covid-19 vaccine. The CoVaH displayed very good fit indices (KMO = .94, RMSEA = 0.049, CFI = .983) and internal consistencies (α values > .89) and was found to have proper convergent, concurrent and discriminant validity in identifying Covid-19 vaccine hesitancy in the general population. The new scale adds to the literature through the identification of the fear of COVID-19 vaccines, as a newly highlighted explanatory variable of COVID-19 vaccine hesitancy, besides the other formerly identified components. The scale, available in English and Hungarian, allows the assessment of vaccine uptake hesitancy and has the potential to help targeted interventions, considering individual factors that interfere with vaccination acceptance.http://dx.doi.org/10.1080/21645515.2021.2007708covid-19fear of covid-19 vaccinerisk perceptionlack of confidenceskepticismvaccine hesitancyscale development |
| spellingShingle | Ibolya Kotta Kinga Kalcza-Janosi Kinga Szabo Eszter Eniko Marschalko Development and Validation of the Multidimensional COVID-19 Vaccine Hesitancy Scale Human Vaccines & Immunotherapeutics covid-19 fear of covid-19 vaccine risk perception lack of confidence skepticism vaccine hesitancy scale development |
| title | Development and Validation of the Multidimensional COVID-19 Vaccine Hesitancy Scale |
| title_full | Development and Validation of the Multidimensional COVID-19 Vaccine Hesitancy Scale |
| title_fullStr | Development and Validation of the Multidimensional COVID-19 Vaccine Hesitancy Scale |
| title_full_unstemmed | Development and Validation of the Multidimensional COVID-19 Vaccine Hesitancy Scale |
| title_short | Development and Validation of the Multidimensional COVID-19 Vaccine Hesitancy Scale |
| title_sort | development and validation of the multidimensional covid 19 vaccine hesitancy scale |
| topic | covid-19 fear of covid-19 vaccine risk perception lack of confidence skepticism vaccine hesitancy scale development |
| url | http://dx.doi.org/10.1080/21645515.2021.2007708 |
| work_keys_str_mv | AT ibolyakotta developmentandvalidationofthemultidimensionalcovid19vaccinehesitancyscale AT kingakalczajanosi developmentandvalidationofthemultidimensionalcovid19vaccinehesitancyscale AT kingaszabo developmentandvalidationofthemultidimensionalcovid19vaccinehesitancyscale AT eszterenikomarschalko developmentandvalidationofthemultidimensionalcovid19vaccinehesitancyscale |